Skip to main content
Year archive

XTL Biopharmaceuticals Ltd. — 2022 filings

All 19 regulatory filings released by XTL Biopharmaceuticals Ltd. (XTLB) in 2022, sourced directly from the official regulator.

19 Filings
2022 Period
2022 filings (19)
Filing Released Lang
Financial results for the nine months ended September 30, 2022
Interim / Quarterly Report 9M 2022
2022-11-29 English
Financial results for the nine months ended September 30, 2022
Report Publication Announcement
2022-11-29 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2022-11-29 English
Financial Results for a Period of Six Months Ending June 30, 2022
Interim / Quarterly Report H1 2022
2022-08-24 English
Financial Results for a Period of Six Months Ending June 30, 2022
Report Publication Announcement
2022-08-24 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2022-08-24 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2022-06-01 English
From 6K- Financial Overview for Three Months Ended March 31, 2022
Interim / Quarterly Report Q1 2022
2022-05-31 English
From 6K- Financial Overview for Three Months Ended March 31, 2022
Report Publication Announcement
2022-05-31 English
Annual Report - Form 20F 2021
Annual Report FY 2021
2022-03-30 English
Annual Report - Form 20F 2021
Report Publication Announcement
2022-03-30 English
ANNUAL REPORT
Annual Report FY 2021
2022-03-30 English
results of the Annual General Meeting of shareholders of the Company, Wednesday, January 26, 2022
AGM Information
2022-01-26 English
results of the Annual General Meeting of shareholders of the Company, Wednesday, January 26, 2022
AGM Information
2022-01-26 English
FORM 6-K
Foreign Filer Report
2022-01-26 English
A meeting which was called for 19/01/2022 was postponed to 26.1.22
Director's Dealing
2022-01-19 English
A meeting which was called for 19/01/2022 was postponed to 26.1.22
AGM Information
2022-01-19 English
A meeting which was called for 19/01/2022 was postponed to 26.1.22
AGM Information
2022-01-19 English
FORM 6-K
Foreign Filer Report
2022-01-19 English